CDCecile Ingrid Djuikoue

Cecile Ingrid Djuikoue

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Cecile Ingrid Djuikoue has a total of 79 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Governance of antimicrobial resistance in Central Africa (2015–2025): a systematic review of policies, One Health coordination and funding

    by Gabriel Tchuente Kamsu, Ingrid Cécile Djuikoue, Benjamin D Thumamo Pokam, Cedric Dylan Seugnou Nana, Clement Ngandjui Yonga, Mallila Georgia Mboupaing, Marie Stella Marehin, Nicole Prisca Makaya Danguil Nieko, Flambel Sanou Kue, Tatiana Banze Mewehu, et al.

    Antimicrobial resistance (AMR) poses a major threat to effective treatment and global health security, with disproportionate impacts in low- and middle-income settings. In Central Africa, health system fragility, limited surveillance capacity and weak multisectoral coordination heighten vulnerability. Despite momentum following the WHO Global Action Plan, the status of AMR governance, One Health coordination and financing in the subregion remains insufficiently characterized. To systematically assess AMR governance in Central Africa (2015–2025), focusing on policy frameworks, One Health coordination and financing mechanisms. We conducted a PRISMA 2020-compliant systematic review registered in PROSPERO (CRD420251082393). Six databases were searched, along with grey literature, including national policy documents, institutional reports and consultations with AMR focal points. Eligible sources addressed AMR policy, coordination, surveillance and funding. Of the 4464 records identified, 27 documents were included (19 peer-reviewed articles, one report, seven national action plans). Evidence was concentrated in Cameroon, with limited data from other countries. National action plans aligned with global standards were identified in six countries, while none were available for Equatorial Guinea or the Republic of Congo. Across the region, governance was characterized by partial policy alignment but weak implementation, limited operationalization of One Health, fragmented surveillance and reliance on external funding. Key constraints included inadequate laboratory capacity, weak stewardship systems and insufficient domestic financing. AMR governance in Central Africa has progressed at the policy level but remains operationally constrained. Bridging the gap between policy and implementation requires strengthened institutionalization of One Health, improved accountability and sustainable domestic investment.


  • Open Access

    Participatory risk assessment in support of the zoonotic disease surveillance system in Cameroon: the case of Ebola Virus Disease and Rift Valley Fever

    by Inès Sopbué Kamguem, Nathalie Kirschvink, Nicolas Antoine-Moussiaux, Florence De Longueville, Cécile Ingrid Djuikoue, Noel K. Joseph, Sophie Molia, Abel Wade, Catherine Linard

    Background Viral haemorrhagic fevers (VHFs) are a group of acute zoonotic diseases with high mortality and morbidity rates infecting both humans and animals. These diseases are endemic in tropical rainforests of central Africa and can lead to severe epidemics. Previous studies have identified Cameroon as a high-risk country, due to favourable ecoclimatic conditions and the presence of susceptible mammals and vectors that have been tested positive for viruses causing VHFs. However, the country has not yet reported any epidemics/epizootics of VHFs such as Rift Valley Fever (RVF) and Ebola Virus Disease (EVD). This research provides novel, context-refined knowledge of perceived risk factors and temporal patterns of RVF and EVD emergence in Cameroon, where epidemiological data on these diseases are limited. Methods The present work proposes a risk assessment of the emergence and transmission of these two zoonoses through the development of an integrated risk assessment tool for identifying high-risk periods and key risk factors. A mixed, semi-quantitative approach involving expert semi-structured interviews, and a monthly calendar was used for data collection. Expert-based risk evaluation was then compared to risk factors derived from the scientific literature. Results For RVF, the wettest months seem to pose the highest risk, with increased inter-animal transmission during livestock transhumance. Key spatial determinants identified by experts included rainfall, host density, reservoirs, vectors, and livestock movements. For EVD spillover risk, human activities and behaviours, land cover, and host density were also identified as critical. Convergences and divergences regarding expert-based and literature-based risk factors for RVF and EVD were observed, with variations concerning livestock trade and ethnic background respectively. The distinction is likely attributable to the differing approaches of contextualization and generalization employed respectively by the two sources of weighting. Conclusions This study shows that, even in regions with no documented disease history, an integrated approach combining expert knowledge and literature-based evidence enables meaningful disease risk assessment, generates novel and context-specific information, and supports the refinement of preventive strategies. The participatory visual tool introduced allows identification and quantification of putative zoonotic risk factors and their temporal dynamics, informing risk mapping, management, and communication.

  • Open Access

    Prevalence and Antibiotic Resistance Pattern of Streptococcus, Staphylococcus, Neisseria meningitidis and Enterobacteriaceae in Two Reference Hospitals of Yaoundé: An Overview before and during COVID-19 Pandemic Era

    by Cecile Ingrid Djuikoue, Willy Yamdeu Djonkouh, Cavin Epie Bekolo, Rodrigue Kamga Wouambo, Raspail Carrel Founou, Paule Dana Djouela Djoulako, Gilder Tonfack Temgoua, Benjamin D. Thumamo Pokam, Nicolas Antoine-Moussiaux, Teke R. Apalata

    The overuse of antibiotic prophylaxis during the COVID-19 pandemic would have led to the devel-opment of antibiotic-resistant bacterial strains, thereby increasing the epidemiological burden of antimicrobi-al resistance. The aim of this study was to determine the prevalence and antibiotic resistance pattern of bacte-ria isolated in 02 referral health facilities in Yaoundé before and during the COVID-19 pandemic era. We conducted a retrospective study over a period of 03 years (from 1 January 2019 to 31 December 2021) in the bacteriology units of the Central and General Hospitals of Yaoundé, Cameroon. The review of the services' registers was done to record bacterial isolates (Streptococcus, Staphylococcus, Neisseria meningitidis and Entero-bacteriaceae) as well as their susceptibility to selected, specific and highly potent antibiotics: Cefixime, Azythromycin and Erythromycin. The relationship between each group of resistant bacteria and the antibiotic of interest was determined by simple linear regression; the comparison of the prevalences of before (2019) and during 2 consecutive years of the COVID-19 pandemic onset (2020 and 2021) was done by the Chi2 test of in-dependence. In all, 426 bacterial strains were included. It appeared that the highest number of bacteria iso-lates and lowest rate of bacterial resistance were recorded during the pre-COVID 2019 period in 2019 (160 isolates vs. 58.8% resistance rate). Conversely, lower bacteria stains but greater resistance burden were rec-orded during the pandemic era (2020 and 2021) with the lowest bacteria amount and peak of bacteria re-sistance registered in 2020, the year of COVID-19 onset (120 isolates vs. 70% resistance in 2020 and 146 iso-lates vs.58.9% resistance in 2021). In contrast to almost all others groups of bacteria where the resistance burden was quite constant over years, the Enterobacteriaceae exhibited greater resistance rate during the pandemic period [60%(48/80) in 2019 to 86.9%(60/69) in 2020 and 64.5%(61/95) in 2021)]. Concerning antibiotics, unlike Erythromycin, Azythromycin related resitance increased during the pandemic period and the resistance to Cefixim tends to decrease the year of the pandemic onset (2020) and re-increase one year therafter. A significant association was found between resistant Enterobacteriaceae strains and Cefixime (R= 0.7; P-value= 0.0001) and also, between resistant Staphylococcus strains and Erythromycin (R= 0.8; P-value= 0.0001). It could be that the more frequent use of these antibiotics has increased resistance rate especially in Enterobacteriaceae. Anticromicrobial resistance should be closely monitor during and after COVID pandemic era.


  • Open Access

    Phenotypic Characterization and Prevalence of Carbapenemase-Producing Acinetobacter baumanii Isolates in Four Health Facilities in Cameroon

    by Cécile Ingrid Djuikoue, Benhamed Nadjia, Paule Dana Djouela Djoulako, Celianthe Guegang, Cedric Seugnou Nana, Rodrigue Kamga Wouambo, Christiane Kiyang Possi, Hélène Valérie Same Njanjo, Yemina Grace Kombeu, Merimé Joel Tchinda Talokou, et al.

    Carbapenems have long been considered as treatment of choice for Gram-Negative Bacteria (GNB) infections, and today the clinical utility of this class is threatened by the emergence and spread of resistance favored by its increasing use. According to the WHO, Acinetobacter baumannii, nosocomial infection agent, tops the list of priority antibiotic-resistant pathogens, considered to be the most risky for humans. This study sought to determine the prevalence of Acinetobacter baumannii strains producing carbapenemases in four health facilities in the Center and Littoral regions of Cameroon and the associated risk factors. An analytical cross-sectional study was conducted over a six-month period from January to June 2022. All Acinetobacter baumanii or suspected strains isolated from pathological samples at the bacteriology laboratory of different health facilities were systematically collected and underwent a re-identification. After successfully subculturing and growing on nutrient agar, re-identification and antimicrobial susceptibility Testing (AST) were performed using the VITEK 2 System and the Kirby-Bauer method according to the guidelines of the Clinical and Laboratory Standards Institute (CLSI). Detection and phenotypic characterization of carbapenemases was performed according to adequate standard procedures. A total of 168/226 clinical isolates of Acinetobacter baumannii were confirmed after re-identification of which 52.69% came from male patients, and 55.09% from participants aged between 10-39 years old and 46.71% from pus samples. A very high resistance rates to all families of antibiotics was noted except to colistin (10.2%). About 40.12% of these strains produced carbapenemases with 62.69% of class B and 37.31% of class A. In addition, frequent hospitalisation was significantly associated to the production of carbapenemase among Acinetobacter baumanii (Ajusted-OR=16.53, P-value<0.0001). This study highlighted the emergence of carbapenemase-producing Acinetobacter baumannii which is increasingly growing. Continuous drug-resistant monitoring and preventive measures could help to prevent and curb the dissemination of A.baumanii resistance genes, especially in hospital settings.

  • Open Access

    Epidemiology of the Acceptance of Anti COVID-19 Vaccine in Urban and Rural Settings in Cameroon

    by Cecile Ingrid Djuikoue, Rodrigue Kamga Wouambo, Majeste Mbiada Pahane, Blaise Demanou Fenkeng, Cedric Seugnou Nana, Joelle Djamfa Nzenya, Flore Fotso Kamgne, Cedric Ngalani Toutcho, Benjamin D. Thumamo Pokam, Teke Apalata

    The COVID-19 pandemic rapidly evolved in December 2019 and to prevent its spread, effective vaccines were produced and made available to the population. Despite their availability so far in Cameroon, the vaccination coverage remains low. This study aimed at describing the epidemiology of the acceptance of vaccines against COVID-19 in some urban and rural areas of Cameroon. A cross-sectional, descriptive and analytical survey was conducted from March 2021 to August 2021 targeting unvaccinated individuals from urban and rural area. After receiving appropriate administrative authorizations and an ethical clearance from the Institutional Review Board (or Ethics Committee) of Douala University (N° 3070CEI-Udo/05/2022/M), a cluster sampling at many degrees was performed and a language-adapted questionnaire was completed by each consenting participant. Data were analyzed using Epi info version 7.2.2.6 software and for p-values < 0.05, the difference was considered as statistically significant. Out of 1053 individuals, 58.02% (611/1053) participants were residing in urban and 41.98% (442/1053) in rural areas. Good knowledge relative to COVID-19 was significantly higher in urban areas as compared to rural areas (97.55% vs. 85.07, p < 0.000). The proportion of respondents who intended to accept the anti COVID-19 vaccine was significantly higher in urban areas than rural areas (42.55% vs. 33.26, p = 0.0047). Conversely, the proportion of anti COVID-19 reluctant respondents thinking that the vaccine can induce a disease was significantly higher in rural areas than urban areas (54 (35.07 vs. 8.84, p < 0.0001). The significant determinants of anti-COVID-19 acceptance were the level of education (p = 0.0001) and profession in the rural areas (p ≤ 0.0001), and only the profession (p = 0.0046) in the urban areas. This study globally showed that anti-COVID-19 vaccination remains a major challenge in urban as well as rural areas in Cameroon. We should continue sensitizing and educating the population about vaccine importance in preventing the COVID-19 spread.


  • Open Access

    Epidemiology of the Acceptance of Anti Covid-19 Vaccine in Urban and Rural Settings in Cameroon

    by Cecile Ingrid Djuikoue, Rodrigue Kamga Wouambo, Majeste Pahane, Blaise Demanou Fenkeng, Cedric Seugnou Nana, Joelle Djamfa Nzenya, Flore Fotso Kamgne, Cedric Ngalani Toutchou, Benjamin D. Thumamo Pokam, Teke Apalata

    The Covid-19 pandemic has rapidly evolved in December 2019 and to prevent its spread, effective vaccines has been produced and made available to the population. Despite their availability so far in Cameroon, the vaccination coverage remains low. This study aimed at describing the epidemiology of the acceptance of vaccines against Covid-19 in some urban and rural areas of Cameroon. A cross-sectional, descriptive and analytical survey was conducted from March 2021 to August 2021 targeting unvaccinated individuals from urban and rural area. After getting appropriate administrative authorizations and an ethical clearance from the Institutional Review Board (or Ethics Committee) of Douala University (N° 3070CEI-Udo/05/2022/M), a cluster sampling at many degrees was performed and a language adapted questionnaire was filled by each consenting participant. Data were analyzed using Epi info version 7.2.2.6 software and for P-values ˂ 0.05, the difference was considered as statistically significant. Out of 1053 individuals, 58.02% (611/1053) participants were residing in urban and 41.98% (442/1053) in rural areas. Good knowledge relative to Covid-19 was significantly higher in urban areas as compared to rural areas (97.55%vs.85.07, P<0.000). The proportion of respondents who intended to accept the anti Covid-19 vaccine was significantly higher in urban areas than rural areas (42.55%vs.33.26, p=0.0047). Conversely, the proportion of anti Covid-19 reluctant respondents thinking that the vaccine can induce a disease was significantly higher in rural areas than urban areas (54 (35.07 vs 8.84, P<0.0001). The significant determinants of anti-COVID-19 acceptance were the level of education (p=0.0001) and profession in the rural areas (p=<0.0001), and only the profession (p=0.0046) in the urban areas. This study globally shows that anti-COVID-19 vaccination remains a major challenge in urban as well as rural area in Cameroon. We should keep sensitizing and educate population about vaccine importance in preventing the COVID-19 spread.

  • Open Access

    Comparative Performance of Serological (IgM/IgG) and Molecular Testing (RT-PCR) of COVID-19 in Three Private Universities in Cameroon during the Pandemic

    by Rodrigue Kamga Wouambo, Cecile Ingrid Djuikoué, Livo Forgu Esemu, Luc Aime Kagoue Simeni, Murielle Chantale Tchitchoua, Paule Dana Djouela Djoulako, Joseph Fokam, Madeleine Singwe-Ngandeu, Eitel Mpoudi Ngolé, Teke Apalata

    Background: COVID-19 remains a rapidly evolving and deadly pandemic worldwide. This necessitates the continuous assessment of existing diagnostic tools for a robust, up-to-date, and cost-effective pandemic response strategy. We sought to determine the infection rate (PCR-positivity) and degree of spread (IgM/IgG) of SARS-CoV-2 in three university settings in Cameroon Method: Study volunteers were recruited from November 2020 to July 2021 among COVID-19 non-vaccinated students in three Universities from two regions of Cameroon (West and Centre). Molecular testing was performed by RT-qPCR on nasopharyngeal swabs, and IgM/IgG antibodies in plasma were detected using the Abbott Panbio IgM/IgG rapid diagnostic test (RDT) at the Virology Laboratory of CREMER/IMPM/MINRESI. The molecular and serological profiles were compared, and p < 0.05 was considered statistically significant. Results: Amongst the 291 participants enrolled (mean age 22.59 ± 10.43 years), 19.59% (57/291) were symptomatic and 80.41% (234/291) were asymptomatic. The overall COVID-19 PCR-positivity rate was 21.31% (62/291), distributed as follows: 25.25% from UdM-Bangangte, 27.27% from ISSBA-Yaounde, and 5% from IUEs/INSAM-Yaounde. Women were more affected than men (28.76% [44/153] vs. 13.04% [18/138], p < 0.0007), and had higher seropositivity rates to IgM+/IgG+ (15.69% [24/153] vs. 7.25% [10/138], p < 0.01). Participants from Bangangté, the nomadic, and the “non-contact cases” primarily presented an active infection compared to those from Yaoundé (p= 0.05, p = 0.05, and p = 0.01, respectively). Overall IgG seropositivity (IgM−/IgG+ and IgM+/IgG+) was 24.4% (71/291). A proportion of 26.92% (7/26) presenting COVID-19 IgM+/IgG− had negative PCR vs. 73.08% (19/26) with positive PCR, p < 0.0001. Furthermore, 17.65% (6/34) with COVID-19 IgM+/IgG+ had a negative PCR as compared to 82.35% with a positive PCR (28/34), p < 0.0001. Lastly, 7.22% (14/194) with IgM−/IgG− had a positive PCR. Conclusion: This study calls for a rapid preparedness and response strategy in higher institutes in the case of any future pathogen with pandemic or epidemic potential. The observed disparity between IgG/IgM and the viral profile supports prioritizing assays targeting the virus (nucleic acid or antigen) for diagnosis and antibody screening for sero-surveys.


  • Open Access

    Profile of Serological (IgM/IgG) and Virological Markers of COVID-19 in Some Private Universities in Cameroon During the Pandemic

    by Rodrigue Kamga Wouambo, Cecile Ingrid Djuikoué, Livo Forgu Esemu, Luc Aime Kagoue Simeni, Murielle Tchitchoua, Paule Dana Djouela Djoulako, Joseph Fokam, Madeleine Singwe-Ngandeu, Eitel Mpoudi Ngolé, Teke Apalata

    Background: COVID-19 remains a rapidly evolving and deadly pandemic worldwide. This necessitates the continuous assessment of existing diagnostic tools for robust, up-to-date and cost-effective pandemic response strategy. We sought to determine the infection rate (PCR-positivity) and degree of spread (IgM/IgG) of SARS-CoV-2 in three university settings in Cameroon Method: Study volunteers were recruited from November 2020 to July 2021 among COVID-19 non-vaccinated students in three Universities from two regions of Cameroon (West and Centre). Molecular testing was performed by RT-qPCR on nasopharyngeal swabs and IgM/IgG antibodies in plasma were detected using the Abbott Panbio IgM/IgG rapid diagnostic test (RDT) at the Virology Laboratory of CREMER/IMPM/MINRESI. The molecular and serological profiles were compared and, pResults: Amongst the 291 participants enrolled (mean age 22.59±10.43 years), 19.59% (57/291) were symptomatic and 80.41 %(234/2691) asymptomatic. Overall COVID-19 PCR-positivity rate was 21.31% (62/291), distributed as follows: 25.25% from UdM-Bangangte; 27.27% from ISSBA-Yaounde and 5% from IUEs/INSAM-Yaounde. Women were more affected than men (28.76% [44/153] vs. 13.04% [18/138], pConclusion: This study calls for a rapid preparedness and response strategy in higher institutes in case of any future pathogen with pandemic or epidemic potentials. The observed disparity between IgG/IgM and viral profile supports prioritizing assays targeting the virus (nucleic acid or antigen) for diagnosis and antibody screening for sero-surveys

  • Open Access

    Intestinal Carriage of Extended Spectrum Beta-Lactamase-Producing Salmonella enterica from Chickens and Poultry Farmers in Dschang, in the Western Region of Cameroon

    by Cecile Ingrid Djuikoue, Cedric Dylan Seugnou Nana, Joelle Nzenya, Charlene Tomi, Noemy Chounna, Olivier Pomte, Benjamin D. Thumamo Pokam, Teke Apalata

    Salmonella enterica is the principal causative agent of salmonellosis, a threat to human health. Because of its high antimicrobial resistance potential, Salmonella enterica has become worrisome, mostly in developing countries where hygiene and antimicrobial usage are defective. This study aimed to determine the epidemiology of the intestinal carriage of Extended Spectrum β-Lactamase producing Salmonella enterica from chickens and poultry farmers in Dschang, a town in the western region of Cameroon. A total of 416 chickens and 72 farmers were sampled between May and October 2020; and Salmonella enterica were isolated and subjected to extended spectrum β-lactamase screening. Logistic regression was used to test for statistical associations using a p-value of ≤0.05. Results from this study revealed that the prevalence of the intestinal carriage of Salmonella enterica for chickens and farmers were 55.77% [51.00; 60.54] and 22.22% [12.62; 31.82], respectively. Meanwhile, the intestinal carriage of Extended Spectrum β-Lactamase producing Salmonella enterica was 23.08% [13.76; 32.40] and 5.55% [0.26; 10.84] from chickens and poultry farmers, respectively. The risk factor for this carriage was revealed to be lack of knowledge by actors in livestock industries of antibiotic resistance. Chickens, just like poultry farmers, represent the starting point of community salmonellosis, which is difficult to cure; therefore, sensitization of breeders is an effective tool for the mitigation of this burden.


  • Open Access

    Phenotypic Characterization and Prevalence of Carbapenemase-Producing Pseudomonas aeruginosa Isolates in Six Health Facilities in Cameroon

    by Cecile Ingrid Djuikoue, Paule Dana Djouela Djoulako, Hélène Valérie Same Njanjo, Christiane Possi Kiyang, Feline Leina Djantou Biankeu, Celianthe Guegang, Andrea Sheisley Didi Tchouotou, Rodrigue Kamga Wouambo, Benjamin D. Thumamo Pokam, Teke Apalata, et al.

    Pseudomonas aeruginosa is a Gram-negative opportunistic pathogen with a great ability to adapt to stress, in particular, to the selective pressure of antibiotics in the hospital environment. This pathogen constitutes a real public health concern, especially in low- and middle-income countries. In Cameroon, little is known about the drug resistance patterns of Pseudomonas aeruginosa. This study sought to determine the prevalence of Pseudomonas aeruginosa strains producing carbapenemases in six health facilities in the center, littoral, and west regions of Cameroon. An analytical cross-sectional study was conducted over a four-month period from July to October 2021. All Pseudomonas aeruginosa or suspected strains isolated from pathological products at the bacteriology laboratory of different health facilities were systematically collected and underwent a re-identification. After growing on cetrimide agar and successfully subculturing on nutrient agar, an oxidase test was performed on pure colonies, followed by biochemical identification (API 20NE system) of the bacterial suspension (0.5McFarland standard). Drug susceptibility testing for the detection of extended-spectrum beta-lactamases of overproduced inducible cephalosporinases and carbapenemases was performed according to adequate standard procedures. Of the 468 isolates collected, 347 (74.14%) were confirmed Pseudomonas aeruginosa after re-identification, of which 34.49% (120/347) produced inducible cephalosporinases (CAZR and C/TS) and 32.26% (112/347) extended-spectrum beta-lactamases. The prevalence of carbapenemase-producing P. aeruginosa (IMPR and C/TR) was 25.07% (87/347), with 17.24% (15/87) class A and 82.76% (72/87) class B. A high rate of resistance to penicillin (piperacillin: 70.58% and ticarcillin: 60.24%) was observed. We also noted a 34.49% resistance to ceftazidime, 30.22% to imipenem against 37.02% to meropenem, and 25.1% to ceftolozane/tazobactam (C/T). These strains also exhibited 79.57% resistance to quinolones and about 26% to aminoglycoside families. Multivariate analysis revealed that carbapenemase-producing Pseudomonas aeruginosa-related infections were significantly associated with hospitalization (p = 0.04), maternity (p = 0.03), surgery (p = 0.04), and intensive care wards (p = 0.04). This study highlighted a high burden of resistant strains of carbapenemase-producing Pseudomonas aeruginosa. Surveillance should be intensified to prevent the dissemination and spread of these strains.